Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care

Projektinformationen

BE-SAFE

ID Finanzhilfevereinbarung: 101057123

DOI

10.3030/101057123

EK-Unterschriftsdatum 18 Mai 2022

Startdatum 1 September 2022

Enddatum 31 August 2027

Finanziert unter

• Health

Gesamtkosten

€ 4 883 232,00

EU-Beitrag

€ 4 883 229,00

Koordiniert durch

UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Websites, patent fillings, videos etc. (3)

Information material for the public

Comprehensive set of information material related to overuse of BSH for the public

BE-SAFE podcasts online

Collection of Podcasts files tackling key topics related BSH addressed health professionals and general public

Public website

Public website up and running to centralise BE-SAFE products

Documents, reports (3)

Clinical pathways and healthcare systems

Current key clinical pathways (or care trajectories) in relation to BSH reduction identified and described in the six participating European countries

Guidelines to reduce BSHs

Trustworthy guidelines to reduce BSHs published on MAGICapp website and BE-SAFE portal

Barriers and enablers to reduce BSHs

Report of the survey, presenting the barriers and enablers to discontinuing BSHs among patients, informal carers and health care professionals in the six European countries

Veröffentlichungen

Peer reviewed articles (6)

Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis

Autoren: Dena Zeraatkar, Sumanth Kumbargere Nagraj, Michael Ling, Tanvir Jassal, Sarah Kirsh, João Pedro Lima, Tyler Pitre, Rachel Couban, Muizz Hussain, Siri Seterelv, Stijn Van de Velde, Katarzyna Gustavsson, Adam Wichniak, Carole E Aubert, Antoine Christiaens, Anne Spinewine, Thomas Agoritsas
Veröffentlicht in: BMJ, Ausgabe 389, 2025, ISSN 1756-1833
Herausgeber: BMJ
DOI: 10.1136/BMJ-2024-081336

Development and validation of the medical attitudes towards deprescribing questionnaire: comment

Autoren: Vladyslav Shapoval; Andrea M. Patey; Séverine Henrard; Anne Spinewine
Veröffentlicht in: Internal and Emergency Medicine, 2024, ISSN 1970-9366
Herausgeber: SIMI
DOI: 10.1007/S11739-024-03675-8

Equipping physicians for benzodiazepine receptor agonists deprescription in older adults: theory-based development of the BE-SAFE intervention

Autoren: François-Xavier Sibille, Joanna Salbert, Lucy Bolt, Vagioula Tsoutsi, Enrico Callegari, Olivia Dalleur, Tokandji Adda, Thomas Agoritsas, Thomas Berger, Carole E. Aubert, Dimitris Dikeos, Antoni Salvà, Begoña Pascual, Ramon Miralles, Torgeir Bruun Wyller, Andrea M. Patey, Jeremy M. Grimshaw, Adam Wichniak, Anne Spinewine, Marie de Saint Hubert
Veröffentlicht in: Research in Social and Administrative Pharmacy, Ausgabe 21, 2025, ISSN 1551-7411
Herausgeber: Elsevier BV
DOI: 10.1016/J.SAPHARM.2025.05.002

Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians

Autoren: Vladyslav Shapoval, Marie de Saint Hubert, Perrine Evrard, François-Xavier Sibille, Carole E. Aubert, Lucy Bolt, Vagioula Tsoutsi, Pinelopi Kollia, Antoni Salvà, Ramon Miralles, Adam Wichniak, Katarzyna Gustavsson, Torgeir Bruun Wyller, Enrico Callegari, Jeremy M. Grimshaw, Justin Presseau, Séverine Henrard, Anne Spinewine
Veröffentlicht in: JAMA Network Open, Ausgabe 8, 2025, ISSN 2574-3805
Herausgeber: American Medical Association (AMA)
DOI: 10.1001/JAMANETWORKOPEN.2024.59883

Deprescribing benzodiazepine receptor agonists for insomnia in older adults

Autoren: Antoine Christiaens, Carole E Aubert, Adam Wichniak, Antoni Salvà Casanovas, Anne Spinewine
Veröffentlicht in: The Lancet, Ausgabe 402, 2023, ISSN 0140-6736
Herausgeber: Elsevier BV
DOI: 10.1016/S0140-6736(23)01562-3

Barriers to and Enablers of Supporting Deprescribing Benzodiazepines in Older Adults: A Survey of European Nonphysician Healthcare Professionals

Autoren: Vladyslav Shapoval, Perrine Evrard, François‐Xavier Sibille, María López‐Toribio, Olivia Dalleur, Carole E. Aubert, Lucy Bolt, Vagioula Tsoutsi, Maria Ntafouli, Laura Fernández Maldonado, Ramon Miralles, Adam Wichniak, Katarzyna Gustavsson, Torgeir Bruun Wyller, Enrico Callegari, Jeremy M. Grimshaw, Justin Presseau, Séverine Henrard, Anne Spinewine
Veröffentlicht in: Basic & Clinical Pharmacology & Toxicology, Ausgabe 137, 2025, ISSN 1742-7835
Herausgeber: Wiley
DOI: 10.1111/BCPT.70100

Other (1)

Guideline - BE-SAFE: Deprescription of benzodiazepine and sedative hypnotics (BSHs) in insomnia disorder

Autoren: Thomas Agoritsas; Sumanth Kumbargere Nagraj; Enrico Callegari; Minna Johansson
Veröffentlicht in: 2023
Herausgeber: MAGIC Evidence Ecosystem Foundation